PS
FLGT icon

Principal Securities’s Fulgent Genetics FLGT Stock Holding History

Principal Securities’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34
Closed -$768 – 2102
2025
Q3 		$768 Sell
34
-36
-51% -$741 ﹤0.01% 3457
2025
Q2 		$1.39K Buy
70
+45
+180% +$877 ﹤0.01% 3253
2025
Q1 		$462 Hold
25
– – ﹤0.01% 3369
2024
Q4 		$462 Hold
25
– – ﹤0.01% 3364
2024
Q3 		$543 Hold
25
– – ﹤0.01% 3265
2024
Q2 		$491 Hold
25
– – ﹤0.01% 3206
2024
Q1 		$543 Hold
25
– – ﹤0.01% 3131
2023
Q4 		$723 Buy
+25
New +$669 ﹤0.01% 3017

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Securities's FLGT Position: Q4 2025 in Review

Principal Securities sold out of Fulgent Genetics (FLGT) in Q4 2025, closing a stake of 34 shares — an estimated $768 sold.

Principal Securities first reported a position in FLGT in Q4 2023 and held it in 8 quarters. The position peaked at $1.39K in Q2 2025. 179 funds tracked by Wall St. Rank hold FLGT as of Q4 2025.

  • Principal Securities reported no remaining Fulgent Genetics position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 34 Fulgent Genetics shares in Q4 2025, an estimated $768.
  • Principal Securities first reported a position in Fulgent Genetics in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Fulgent Genetics position peaked at $1.39K in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.